Price $5.19 |
Market Cap
1.11B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
192.1
|
P/B
-
|
P/S
0.35
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
2.0
|
Op. Cash Flow
578.7K
|
FCF
2.1
|
|
Op. Margin
19.10%
|
Net Margin
3.40%
|
ROE
-13.90%
|
ROI
8.40%
|
|
ROA
1.00%
|
EPS Growth
134.20%
|
Current Ratio
1.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Myriad Genetics, Inc. (MYGN) | $31.45 | - | - | 2.41B | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $3.39 | - | - | 43M | Strong Buy |
| Lannett Company, Inc. (LCI) | $4.72 | - | - | 186.5M | Strong Buy |
| Genesis Healthcare Inc (GENN) | $0.25 | - | - | 53.6M | Strong Buy |
| Predictive Technology Group In (PRED) | $0.21 | - | - | 131.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
